关于公司
MBio Diagnostics is the innovator of the proprietary point-of care LightDeck® platform that delivers highly sensitive, lab-quality results in minutes. The LightDeck platform consists of a robust, portable fluorescence analyzer and disposable, multiplex test cartridges. The test procedure is simple, enabling untrained users to perform testing on-the-spot. Brava Diagnostics, the IVD division of MBio, is developing a portfolio of multiplex tests including panels for COVID-19, host-response panels for acute infections and sepsis and panels of cardiac markers for heart attack and heart failure. The LightDeck platform is also commercialized for veterinary diagnostics and for environmental testing.
US
未验证公司
业务透明度
- 未验证公司信息
- 向他们的客户询问评论
- 没有回复负面评论